Ophthalmology CME
11 - 12 of 12 results
- FREE
Glaucoma: Therapeutic updates best practices and barriers to effective care
Activity Description / Statement of Need:
In this online, self-learning activity:
Glaucoma, a heterogeneous disease leading to progressive damage to the optic nerve, causes irreversible vision loss and affects approximately 64 million people worldwide.The prevalence of glaucoma is increasing, and more than 100 million people will have glaucoma by 2040. Approximately half of all individuals with glaucoma are unaware of their condition due to the asymptomatic nature of the disease. Although the incidence of glaucoma-related blindness has decreased over the last 20 years, thanks to effective management strategies, 13% to 40% of people with glaucoma still develop unilateral or bilateral blindness, typically at a rate of 1.1% per year.
Target Audience:
The following healthcare professionals: Ophthalmologists; physician assistants, nurse practitioners, nurses, and pharmacists with an interest in ophthalmology or diseases affecting the eye; and any other healthcare professionals with an interest in or who clinically encounter patients with glaucoma.
See full details chevron_right- Cost: Free
- Credit hours: 1
- CME credits awarded by: ScientiaCME
- Format: On-Demand Online
- Material last updated: 04/24/2021
- Expiration of CME credit: 04/24/2023
- FREE
Seeing through the challenges of ocular allergy: Optimization of diagnosis and treatment strategies
Activity Description / Statement of Need:
In this online, self-learning activity:
Ocular allergy (OA), also known as allergic eye disease, is an ocular surface hypersensitivity disorder resulting from an abnormal immunologic response of the eye to various antigens. It is not a single clinical entity, rather it includes the following conditions with differing hypersensitivity mechanisms, diagnostic criteria, pathogenesis, and management strategies: seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis, giant papillary conjunctivitis, and contact dermatoconjunctivitis. OA affects approximately 40% of the global population, with SAC and PAC specifically affecting 15 to 25%. Ocular itch associated with SAC and PAC is the hallmark symptom of the disease. The multifactorial dimensions of OA contribute to economic ramifications in the United States (US) estimated at $2 billion annually in prescriptions, with the costs associated with over-the-counter (OTC) medications projected to be tenfold higher than prescription sales.
Target Audience:
The following HCPs: ophthalmologists, allergists, and general practitioners; physician assistants and nurse practitioners in the aforementioned areas of specialty; and any other clinicians involved or interested in the treatment of ocular allergy.
See full details chevron_right- Cost: Free
- Credit hours: 1
- Format: On-Demand Online
- Material last updated: 04/22/2023
- Expiration of CME credit: 04/22/2025
